T1	Participants 29 72	minimally invasive mitral-valve operations.
T2	Participants 275 315	patients with peripheral vessel disease.
T3	Participants 330 471	20 patients were prospectively randomized into 2 groups, to undergo either standard femoral (group A) or direct aortic cannulation (group B).
